Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Consulting Fee | $31,472 | 1 | 82.3% |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $4,301 | 3 | 11.2% |
| Food and Beverage | $2,392 | 75 | 6.3% |
| Travel and Lodging | $72.77 | 1 | 0.2% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Ceribell, Inc. | $31,472 | 1 | $0 (2019) |
| Neurelis, Inc. | $4,699 | 14 | $0 (2024) |
| SK Life Science, Inc. | $547.63 | 11 | $0 (2024) |
| ARGENX US, INC. | $274.04 | 4 | $0 (2024) |
| ABBVIE INC. | $254.54 | 9 | $0 (2024) |
| UCB, Inc. | $169.28 | 6 | $0 (2024) |
| JAZZ PHARMACEUTICALS INC. | $156.47 | 7 | $0 (2023) |
| Teva Pharmaceuticals USA, Inc. | $133.23 | 6 | $0 (2024) |
| Eisai Inc. | $86.83 | 3 | $0 (2024) |
| Lundbeck LLC | $65.84 | 3 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $5,776 | 45 | Neurelis, Inc. ($4,627) |
| 2023 | $989.38 | 34 | ARGENX US, INC. ($179.38) |
| 2019 | $31,472 | 1 | Ceribell, Inc. ($31,472) |
All Payment Transactions
80 individual payment records from CMS Open Payments — Page 1 of 4
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/18/2024 | PFIZER INC. | ZAVZPRET (Drug) | Food and Beverage | In-kind items and services | $24.22 | General |
| Category: PAIN | ||||||
| 12/11/2024 | Neurelis, Inc. | VALTOCO (Drug) | Food and Beverage | In-kind items and services | $21.15 | General |
| Category: EPILEPSY | ||||||
| 12/07/2024 | SK Life Science, Inc. | — | Food and Beverage | In-kind items and services | $73.30 | General |
| 12/06/2024 | Neurelis, Inc. | VALTOCO (Drug) | Food and Beverage | In-kind items and services | $13.15 | General |
| Category: EPILEPSY | ||||||
| 12/05/2024 | SK Life Science, Inc. | — | Food and Beverage | In-kind items and services | $125.49 | General |
| 12/05/2024 | Neurelis, Inc. | VALTOCO (Drug) | Food and Beverage | In-kind items and services | $122.20 | General |
| Category: EPILEPSY | ||||||
| 11/19/2024 | Eisai Inc. | Leqembi (Drug) | Food and Beverage | In-kind items and services | $34.48 | General |
| Category: Neurology | ||||||
| 11/15/2024 | Grifols USA, LLC | Gamunex-C (Biological) | Food and Beverage | In-kind items and services | $26.37 | General |
| Category: Immunology and Neurology | ||||||
| 11/13/2024 | Alexion Pharmaceuticals, Inc. | ULTOMIRIS (Biological) | Food and Beverage | In-kind items and services | $28.37 | General |
| Category: Rare Disease | ||||||
| 11/12/2024 | SK Life Science, Inc. | — | Food and Beverage | In-kind items and services | $29.12 | General |
| 11/07/2024 | ARGENX US, INC. | VYVGART HYTRULO (Drug) | Food and Beverage | In-kind items and services | $24.79 | General |
| Category: Neurology | ||||||
| 11/05/2024 | Novartis Pharmaceuticals Corporation | KESIMPTA (Drug) | Food and Beverage | In-kind items and services | $26.39 | General |
| Category: Neurology | ||||||
| 11/04/2024 | Lilly USA, LLC | AMYVID (Drug), KISUNLA | Food and Beverage | In-kind items and services | $24.22 | General |
| Category: Neuroscience | ||||||
| 10/29/2024 | Lundbeck LLC | VYEPTI (Biological) | Food and Beverage | Cash or cash equivalent | $20.24 | General |
| Category: NEUROLOGY | ||||||
| 10/22/2024 | Neurelis, Inc. | VALTOCO (Drug) | Food and Beverage | In-kind items and services | $25.59 | General |
| Category: EPILEPSY | ||||||
| 10/16/2024 | SK Life Science, Inc. | XCOPRI (Drug) | Food and Beverage | In-kind items and services | $122.40 | General |
| Category: Neurology | ||||||
| 10/16/2024 | SK Life Science, Inc. | — | Food and Beverage | In-kind items and services | $30.49 | General |
| 09/24/2024 | Eisai Inc. | Leqembi (Drug) | Food and Beverage | In-kind items and services | $27.56 | General |
| Category: Neurology | ||||||
| 09/17/2024 | ABBVIE INC. | UBRELVY (Drug), QULIPTA | Food and Beverage | In-kind items and services | $18.06 | General |
| Category: NEUROSCIENCE | ||||||
| 09/13/2024 | MITSUBISHI TANABE PHARMA AMERICA, INC. | RADICAVA (Drug), RADICAVA ORS | Food and Beverage | In-kind items and services | $24.05 | General |
| Category: AMYOTROPHIC LATERAL SCLEROSIS | ||||||
| 09/10/2024 | UCB, Inc. | — | Food and Beverage | In-kind items and services | $23.35 | General |
| 09/03/2024 | Lundbeck LLC | VYEPTI (Biological) | Food and Beverage | Cash or cash equivalent | $24.76 | General |
| Category: NEUROLOGY | ||||||
| 08/29/2024 | SK Life Science, Inc. | — | Food and Beverage | In-kind items and services | $31.12 | General |
| 08/22/2024 | Neurelis, Inc. | VALTOCO (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $1,608.00 | General |
| Category: EPILEPSY | ||||||
| 08/19/2024 | Novartis Pharmaceuticals Corporation | KESIMPTA (Drug) | Food and Beverage | In-kind items and services | $26.62 | General |
| Category: Neurology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 8 | 301 | 359 | $158,045 | $37,400 |
| 2022 | 6 | 211 | 256 | $114,058 | $26,772 |
| 2021 | 8 | 197 | 269 | $105,574 | $27,913 |
| 2020 | 1 | 17 | 25 | $16,800 | $4,425 |
All Medicare Procedures & Services
25 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 95720 | Measurement of brain wave activity with video (veeg), 12-26 hours with review and report by health care professional | Facility | 2023 | 69 | 116 | $88,256 | $18,062 | 20.5% |
| 95718 | Measurement of brain wave activity with video (veeg), 2-12 hours with review and report by health care professional | Facility | 2023 | 43 | 48 | $24,842 | $4,825 | 19.4% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Facility | 2023 | 28 | 34 | $5,406 | $3,124 | 57.8% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2023 | 17 | 17 | $9,503 | $2,935 | 30.9% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 20 | 20 | $9,360 | $2,626 | 28.1% |
| 95816 | Measurement of brain wave activity (eeg), awake and drowsy | Facility | 2023 | 55 | 55 | $9,418 | $2,217 | 23.5% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Facility | 2023 | 19 | 19 | $2,033 | $1,153 | 56.7% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 13 | 13 | $4,881 | $1,121 | 23.0% |
| 95819 | Measurement of brain wave activity (eeg), awake and asleep | Facility | 2023 | 21 | 21 | $3,178 | $869.24 | 27.4% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Facility | 2023 | 16 | 16 | $1,168 | $467.87 | 40.1% |
| 95720 | Measurement of brain wave activity with video (veeg), 12-26 hours with review and report by health care professional | Facility | 2022 | 44 | 74 | $75,316 | $11,845 | 15.7% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Facility | 2022 | 44 | 53 | $8,553 | $5,560 | 65.0% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Facility | 2022 | 64 | 69 | $7,552 | $4,375 | 57.9% |
| 95718 | Measurement of brain wave activity with video (veeg), 2-12 hours with review and report by health care professional | Facility | 2022 | 29 | 29 | $19,344 | $2,940 | 15.2% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Facility | 2022 | 13 | 13 | $1,953 | $1,365 | 69.9% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Facility | 2022 | 17 | 18 | $1,339 | $686.73 | 51.3% |
| 95720 | Continuous measurement of brain wave activity with video (veeg), 12-26 hours, with health care professional analysis, interpretation and report | Facility | 2021 | 39 | 70 | $58,411 | $11,731 | 20.1% |
| 99215 | Established patient outpatient visit, total time 40-54 minutes | Facility | 2021 | 43 | 53 | $7,930 | $5,745 | 72.4% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2021 | 29 | 57 | $12,540 | $3,270 | 26.1% |
| 95718 | Continuous measurement of brain wave activity with video (veeg), 2-12 hours, with health care professional analysis, interpretation and report | Facility | 2021 | 22 | 23 | $13,420 | $2,480 | 18.5% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Facility | 2021 | 24 | 24 | $2,514 | $1,795 | 71.4% |
| 99222 | Initial hospital inpatient care, typically 50 minutes per day | Facility | 2021 | 13 | 14 | $6,517 | $1,502 | 23.0% |
| 95816 | Measurement and recording of brain wave (eeg) activity, awake and drowsy | Facility | 2021 | 16 | 17 | $3,472 | $811.91 | 23.4% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Facility | 2021 | 11 | 11 | $770.00 | $579.11 | 75.2% |
| 95720 | Continuous measurement of brain wave activity with video (veeg), 12-26 hours, with health care professional analysis, interpretation and report | Facility | 2020 | 17 | 25 | $16,800 | $4,425 | 26.3% |
About Dr. Barbara Decker, MD
Dr. Barbara Decker, MD is a Neurology healthcare provider based in Fredericksburg, Virginia. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 03/30/2014. The National Provider Identifier (NPI) number assigned to this provider is 1275951022.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Barbara Decker, MD has received a total of $38,238 in payments from pharmaceutical and medical device companies, with $5,776 received in 2024. These payments were reported across 80 transactions from 20 companies. The most common payment nature is "Consulting Fee" ($31,472).
As a Medicare-enrolled provider, Decker has provided services to 726 Medicare beneficiaries, totaling 909 services with total Medicare billing of $96,509. Data is available for 4 years (2020–2023), covering 25 distinct procedure/service records.
Practice Information
- Specialty Neurology
- Other Specialties Neurology, Epilepsy
- Location Fredericksburg, VA
- Active Since 03/30/2014
- Last Updated 10/29/2025
- Taxonomy Code 2084N0400X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1275951022
Products in Payments
- VALTOCO (Drug) $4,699
- VYVGART (Drug) $179.38
- UBRELVY (Drug) $176.79
- EPIDIOLEX (Drug) $156.47
- AJOVY (Biological) $133.23
- XCOPRI (Drug) $122.40
- VYVGART HYTRULO (Drug) $94.66
- Leqembi (Drug) $86.83
- QULIPTA (Drug) $77.75
- Nayzilam (Drug) $75.97
- VYEPTI (Biological) $65.84
- KESIMPTA (Drug) $53.01
- AMYVID (Drug) $49.78
- RADICAVA (Drug) $48.84
- ULTOMIRIS (Biological) $44.50
- NURTEC ODT (Drug) $38.83
- REXULTI (Drug) $29.16
- Gamunex-C (Biological) $26.37
- ZAVZPRET (Drug) $24.22
- UPLIZNA (Biological) $22.92
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Neurology Doctors in Fredericksburg
Dr. Dale Pcsolyar, M.d, M.D
Neurology — Payments: $109,051
Sandra Crouse, Md, MD
Neurology — Payments: $11,893
Dr. Matthew Stotz, M.d, M.D
Neurology — Payments: $10,055
Ronald Stotz, Md, MD
Neurology — Payments: $8,917
Theresa Weber, Md, MD
Neurology — Payments: $4,580
Dr. Richard Erwin, M.d, M.D
Neurology — Payments: $2,730